AGIOS PHARMACEUTICALS, INC. 10-K filing
Filed 2026-02-12 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001439222-26-000025
- Form type
- 10-K
- CIK
- 0001439222
- Primary document
- https://www.sec.gov/Archives/edgar/data/1439222/000143922226000025/agio-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AGIOS PHARMACEUTICALS, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $54.0M | - | - |
| Cost Of Revenue | $6.3M | - | - |
| Operating Income | $-472.1M | - | - |
| Net Income | $-412.8M | - | - |
| Eps Basic | -7.12 | - | - |
| Eps Diluted | -7.12 | - | - |
| Cash And Equivalents | $89.1M | - | - |
| Total Assets | $1.3B | - | - |
| Total Liabilities | $104.1M | - | - |
| Shareholders Equity | $1.2B | - | - |
| Operating Cash Flow | $-373.0M | - | - |
| Capital Expenditures | $4.3M | - | - |